Delivery Order SPE2DB20D9127-SPE2DB21FY32J
- Not listed
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) as a delivery order under the SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026. The contract provides the DLA with a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract valued at up to $499,999,999. The order is for $33,075.24 to provide the DLA with various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables such as Xolair, Trikafta, Keytruda, Botox, and Nucala. The contract has a...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The contract covers a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The current...
- This award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The IDC enables the DLA to issue firm fixed-price orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order under the SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999, which allows the DLA to issue firm fixed-price orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The specific...
- This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract is a $499,999,999 Indefinite Delivery Contract (IDC) valid through November 2026 that allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order (SPE2DB21FY22L) issued by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999. The IDC, which is valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The contract covers a diverse range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans'...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, under the SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The contract is for the provision of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities...
- This contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under the DLA's SPE2DB program, a $499,999,999 Indefinite Delivery Contract (IDC) that provides a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The delivery order, valued at $25,845.50, covers the supply...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB21FY32JDelivery Order
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC). The IDC is valued at $499,999,999 and is valid through November 2026, enabling the DLA to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide. The specific delivery order awarded to DMS Pharmaceutical Group Inc. has a ceiling value of $30,995.22 and covers the provision of various pharmaceutical products and medical supplies, such as Xolair, Trikafta, Keytruda, Botox, and Nucala, to the DLA's Philadelphia branch. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure this direct federal award. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated its capability to provide a diverse array of pharmaceutical products to the DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.0k | 4/22/21 |